Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) Christoph J. RagethElizabeth A. M. O’FlynnZsuzsanna Varga Review Open access 30 November 2018 Pages: 279 - 296
Identifying adherence barriers to oral endocrine therapy among breast cancer survivors Rutugandha ParanjpeGrace JohnSusan Abughosh Review 06 December 2018 Pages: 297 - 305
Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy Kristin E. RojasThais A. FortesPatrick I. Borgen Review 08 December 2018 Pages: 307 - 313
Clinical findings and outcomes of MRI staging of breast cancer in a diverse population Akshara RaghavendraJulie WecslerDebu Tripathy Review 12 December 2018 Pages: 315 - 324
Peer support interventions for breast cancer patients: a systematic review Jieman HuXue WangXuedong Fang Review 02 January 2019 Pages: 325 - 341
An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer Anagha GogateJason S. RotterStephanie B. Wheeler Review 02 January 2019 Pages: 343 - 355
The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis Pierre O’BrienKara MathesonTallal Younis Review 02 January 2019 Pages: 357 - 363
Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours Sue Zann LimCedric Chuan Young NgPuay Hoon Tan Preclinical study 03 December 2018 Pages: 365 - 373
KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients Xi-Mei WangZhen ZhangChunhua Xiao Preclinical study 08 December 2018 Pages: 375 - 385
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer Chitra JosephMaariya ArshadEmad A. Rakha Preclinical study 15 December 2018 Pages: 387 - 399
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies Berry ButtonSarah CroessmannBen Ho Park Preclinical study 17 December 2018 Pages: 401 - 412
Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence Matthew A. LyesSturgis PayneRobin E. Bachelder Preclinical study Open access 29 December 2018 Pages: 413 - 422
Combination of different types of elastography in downgrading ultrasound Breast Imaging-Reporting and Data System category 4a breast lesions Xueyi ZhengYini HuangJianhua Zhou Clinical trial 04 December 2018 Pages: 423 - 432
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial O. NanniD. AmadoriMYME investigators Clinical trial 07 December 2018 Pages: 433 - 442
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer Dilan A. PatelJing XiJian L. Campian Clinical trial 02 January 2019 Pages: 443 - 452
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer Marius WunderleJutta PretscherClaudia Rauh Clinical trial 02 January 2019 Pages: 453 - 461
Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study Orit GolanYoav AmitaiTehillah S. Menes Epidemiology 03 December 2018 Pages: 463 - 468
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families Talia DonenbergSophia GeorgeJudith Hurley Epidemiology 04 December 2018 Pages: 469 - 477
Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands Carmen van DooijeweertPaul J. van DiestIvette A. G. Deckers Epidemiology Open access 11 December 2018 Pages: 479 - 488
Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact Anna L. V. JohanssonCaroline E. WeibullMats Lambe Epidemiology Open access 14 December 2018 Pages: 489 - 503
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011 Judith MalmgrenMarc HurlbertHenry G. Kaplan Epidemiology Open access 17 December 2018 Pages: 505 - 514
Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV–VI Joo Heung KimKwang Hyun YoonByeong-Woo Park Epidemiology 17 December 2018 Pages: 515 - 524
The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same? Isabelle ThébergeNathalie VandalLinda Perron Epidemiology 18 December 2018 Pages: 525 - 535
Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer Emmanuel CaruanaYohann FoucherEtienne Dantan Epidemiology 02 January 2019 Pages: 537 - 542
Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T Laura Duran-LozanoGemma MontalbanOrland Diez Brief Report 14 December 2018 Pages: 543 - 550
Ectopic breast tissue and cancer Alessandro SindoniMaria Gioffré-FlorioFausto Famá Letter to the Editor 13 December 2018 Pages: 551 - 552